Lung cancer remains one of the most prevalent and deadly malignancies worldwide. This session will focus on advances in thoracic oncology, early detection, and multidisciplinary management strategies. Researchers will discuss molecular profiling, targeted therapies, and immunotherapeutic approaches. Recent breakthroughs in lung cancer research will be highlighted.
Presentations will explore screening programs, diagnostic innovations, and personalized treatment modalities. Participants will gain insights into surgical, medical, and radiation oncology approaches. Emerging technologies in precision oncology and biomarker discovery will also be discussed. Clinical experiences and translational research findings will be presented.
The session will address challenges related to treatment resistance and long-term patient outcomes. Experts will discuss future opportunities in thoracic oncology research. Collaboration among oncologists, pulmonologists, and researchers will be encouraged. This session aims to improve lung cancer diagnosis and treatment strategies.